Mr. Friedmann spent 28 years in the healthcare (HC) industry, of which 14 years were with GEHC in a number of Sales and Marketing leadership positions in EU. Former CMO & BD Director for South EU (2007-2014). Prior roles: Marketing Director Diagnostics Imaging Drugs, Product Mgr. Cardiac Imaging at Amersham Health, Sales Manager at Life Technologies (LT, former Gibco-BRL company).Strong strategic foundation acquired through 3 decades of Sales, Marketing & BD roles at GEHC, Amersham and LT.Juan Antonio led the GE account, growing its market share and winning a major public tender. Juan Antonio supported EU projects for key New Product Innovations, and x-industry partnerships to open up new sales channels for GE. And re-positioned several products to increase MS, too.Co-founded 37Celsius Capital Partners LLC, a digital health fund, is serving to grow TeleMedCare LLC, founded a Sport Clinic in Madrid and helped Boston Sci. new solutions in EU. He served on the EU Academic Innovation Programs, and in the Disease Initiatives EU Working Group at GE. Member of the Innovation Committee of IDIS (Spanish Private HC Association), and of the Innovation Committee of the Spanish Medtech Trade Association (Fenin). He received a Master degree in Marketing (ESIC), Master degree in Pharmaceutical Marketing & Management (EADA) and a Bachelor’s degree in Chemistry and Chemical Engineering (UAB) Barcelona. He received several Leadership & Executive training programs in GE and GE Healthcare.

Customer-focused Life Sciences Solutions Selling Executive with 20 years of over achievement in software applications and consulting services. Jon has helped dozens of Life Sciences innovators commercialize their assets from pre-launch (HEOR and value generation, pricing, market access and reimbursement, full branding and agency services) to launch (HUB services and integrated specialty pharma dispensation, 3PL) and in-market revenue maximization (sales teams, affordability and adherence programs, revenue management, process optimization). Before Eversana Jon had several sales and executive roles at Teranode, OpenText, and Model N.

Marc Filerman is Managing Partner at German Accelerator Life Sciences – an organization accelerating international growth of German startups. With over 30 years in healthtech, Marc has expertise in market development, commercialization, and innovation acceleration, and broad experience leading marketing, sales, and business development for large companies and startups. Marc co-founded a molecular imaging startup, and was Chief Commercial Officer at an NIH-funded hometech venture. Prior to that, Marc held multiple corporate leadership positions including VP of Global Marketing at iCAD, and Group Director of Marketing at Smith & Nephew. Marc holds MS and BS engineers degrees from MIT, did his graduate work at the MIT AI Lab, and started his career designing ultrasound imaging equipment.

Jordi is a renowned expert in social agents, emotion artificial intelligence, cloud computing platforms, healthtech, and edtech with over 100 publications on international conferences, journals, and book chapters. He is now the co-founder and CSO of the LIGHTHOUSE – Disruptive Innovation Group. During this career Jordi was senior Research Scientist Sant Joan de Déu Innovation and R&D department– Barcelona Children’s Hospital Foundation, CSO of the Empowered Brain Institute, Affiliate Researcher at Tufts University, Affiliate Researcher at MIT Media Lab, CSO of the Boston Exponential Hub at NTT DATA CORP, Robotics Innovation and Scientific Manager at NextGen everis-NTT DATA. Jordi graduated as Telecommunications Engineering (EE/CS) from La Salle - Ramon Llull University, Barcelona (Spain)

Healthcare and management executive with over 15 years experience in strategy, operations, and Innovation. Committed to building a healthier, equitable and efficient healthcare system. Nnamdi is the Director of Corporate Strategy at Indiana University Health, Investor at What If Ventures and Board Member at The Coneflower Institute & Liberty Grove Schools.

Prof Brugada is a Senior Consultant at the Hospital Clínic, Barcelona and Head of the Arrhythmia Section at the Pediatric Hospital Sant Joan de Déu and Head of the Arrhythmia Unit of the Clínica Quirón Palmaplanas and Clínica Rotger in Palma de Mallorca and Clínica Girona in Girona. Consultant in Clínica Teknon, Barcelona. Past President of the European Heart Rhythm Association. He has published more than 500 original papers in the most relevant international journals, with an H index of 83 and more than 25.000 citations. Prof. Brugada held also the post of Deputy Editor of the European Journal of Cardiology. He is member of several scientific societies and is Professor of Cardiology at the University of Barcelona since 1998. He discovered, treated and found the genetic cause of a rare syndrome causing Sudden Death, which is known in the scientific literature as “Brugada Syndrome”. He is Doctor Honoris Causa by several Universities around the world and he has received multiple Prices and Awards including the Fritz-Acker Award of the German Society of Cardiology, the Josep Trueta Award of the Catalan Academy of Medical Sciences, and the Rey Jaime I Award in clinical medicine.

Juan J. Bestard Perelló holds dual degrees in Medicine and Law, with a Master’s in Public Health and an MBA. With a specialty in Preventive Medicine and Public Health, they have also trained in Health Economics at Johns Hopkins. Juan have held prominent roles, including President of the Health Law Section at ICIAM, Head of University Studies at Juaneda Healthcare Network, and General Director of IB-Salut. Juan have worked extensively as a medical advisor, academic director, and executive in various health organizations, including roles in Madrid’s health administration and PAHO. Currently, he teach and coordinate at UNIR and UAM, with over 70 courses taught, 160 lectures, and numerous publications, including 12 books.